Antidiabetic plants and their active constituents

Phytomedicine

Volumn 2, Issue 2, 1995, Pages 137-189

  Marles, R J ^a   Farnsworth, N R ^b  

^a BRANDON UNIVERSITY   (Canada)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

antidiabetic plants; bioassays for hypoglycemic agents; botany; chemistry; mechanism of action

Indexed keywords

EID: 0028835878     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0944-7113(11)80059-0     Document Type: Review

References (264)

1. Hypoglycaemic effect of the Salt Bush (Atriplex halimus) — a feeding source of the Sand Rat (Psammomys obesus)
2. Herbal drugs in the treatment of diabetes
3. Studies on the activity of individual plants of an antidiabetic plant mixture
4. “Tropical” diabetes — an elusive concept
5. Gliclazide: review of metabolic and vascular action
6. Search for new pesticides from higher plants
7. Responsible use of animals in research
8. Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity test
9. Forskolin: From an ayurvedic remedy to a modern agent
10. Maya medicinal plants of San Jose Succotz, Belize
11. Interaction between curry ingredient (Karela) and drug (Chlorpropamide)
12. Orally effective hypoglycemic agent from Vinca rosea
13. Insulin resistance in Type I ( insulin-dependent) diabetes following hypoglycemia — evidence for the importance of B-adrenergic stimulation
14. Effect of allyl propyl disulphide isolated from onion (Allium cepa L.) on glucose tolerance of alloxan diabetic rabbits
15. Traditional plant medicines as treatments for diabetes
16. Traditional plant remedies for diabetes
17. Cerasee, a traditional treatment for diabetes. Studies in normal and streptozotocin diabetic mice
18. The role of traditional medicine in primary health care
19. Mechanism of action of sulphonylureas with special reference to the extrapancreatic effect: An overview
20. Insulin resistance in skeletal muscle in patients with NIDDM
21. An improved method for the isolation of hepatocytes from liver slices. Selective removal of trypan blue-dyeable cells
22. Diabetes in developing countries and unusual populations
23. Role of drugs in recovery of metabolic function of rat brain following severe hypoglycemia
24. Coumarins and caterpillars: A case for coevolution
25. Practicable measures for the detection and care of diabetes mellitus in developing countries
26. Death of a beta cell: homicide or suicide?
27. Sulfonylurea receptors, ion channels and fruit flies
28. Financing the care of diabetes mellitus in the U.S
29. Guar-enriched pasta and guar gum in the dietary treatment of Type II diabetes
30. The insulin-like properties of vanadium: a curiosity or a perspective for the treatment of diabetes?
31. α-Adrenergic blockade improves glucose-potentiated insulin secretion in non-insulin-dependent diabetes mellitus
32. The mode of action and clinical pharmacology of gliclazide: a review
33. Food and Drug Regulations — Amendment (Schedule No. 705)
34. Vitamin E reduction of protein glycosylation in diabetes
35. On the presence of an antidiabetic principle in Momordica charantia
36. Abrusides A-D, four novel sweet-tasting triterpene glycosides from the leaves of Abrus precatorius
37. Islet microencapsulation: a review
38. Critical review of the toxicology of coumarin with special reference to interspecies differences in metabolism and hepatotoxic response and their significance to man
39. Bioengineering in development of the hybrid artificial pancreas
40. Tolbutamide as mimic of glucose on B-cell electrical activity. ATP-sensitive K+ channels as common pathway for both stimuli
41. ATP-sensitive K+ channels in pancreatic B-cells. Spare-channel hypothesis
42. New approach for oral administration of insulin with polyalkylcya-noacrylate nanocapsules as drug carrier
43. Hypoglycaemic agents from traditional plant treatments for diabetes
44. Indolizines II. Search for potential oral hypoglycemic agents
45. The triumvirate β-cell, muscle, liver. A collusion responsible for NIDDM
46. Pathogenesis of NIDDM. A balanced overview
47. Extracts of protozoa contain materials that react specifically in the immunoassay for guinea pig insulin
48. Phytochemical and toxicological screening of household ornamental plants potentially toxic to humans
49. Photoactivated biocides from higher plants
50. Butterflies and plants: A study in coevolution
51. Insulin binding and transport in adipocytes in neonatal streptozocin-injected rat model of diabetes melitus
52. The pharmacognosy of the periwinkles: Vinca and Catharanthus
53. Medicinal plants in therapy
54. Hypoglycemic plants
55. Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders
56. Studies of the action of hypoglycin-A, an hypoglycaemic substance
57. Oral hypoglycemic agents
58. Failure of glucose tolerance factor-containing brewer's yeast to ameliorate spontaneous diabetes in C57BL/KsJ DB/DB mice
59. Toxicity of abrin and ricin in mice and dogs
60. Effects of guar and carob gums on glucose, insulin and cholesterol plasma levels in the rat
61. The enzymic isolation of adult rat hepatocytes in a functional and viable state
62. 1-adrenergic-mediated and glucagon-mediated actions in isolated rat hepatocytes
63. Glucose transport and NIDDM
64. Inhibition of protein-tyrosine kinase activity by flavanoids and related compounds
65. Cholinergics, anticholinesterases, and antispasmodics
66. Fenugreekine, a new steroidal sapogenin-peptide ester of Trigonella foenum-graecum
67. Problems of diabetic care in tropical countries
68. Intranasal administration of insulin to humans
69. Diabetes in American Indians: A growing problem
70. Interaction of sulfonylureas with pancreatic B-cells. A study with glyburide
71. Molecular physiology and genetics of NIDDM. Importance of metabolic staging
72. Ethnopharma-cognostic observations on Panamanian medicinal plants. Part I
73. Traditional medical practices and medicinal plant usage on a Bahamian island
74. Antidiabetic effect of tecomine and tecostanine
75. Hypoglycaemic properties of tecomine and tecostanine. Letters to the Editor
76. Maninder: Hypoglycemic plants — a review
77. Therapeutic potential of acarbose as first-line drug in NIDDM insufficiently treated with diet alone
78. Preclinical and clinical studies with latex from Ficus glabrata HBK, a traditional intestinal anthelmintic in the Amazonian area
79. Experimental pancreatic transplantation in diabetes
80. Drugs affecting sugar metabolism
81. Diazoxide and D600 inhibition of insulin release. Distinct mechanisms explain the specificity for different stimuli
82. Effects of epicatichin on rat Islets of Langerhans
83. Mechanisms of hypoglycemic activity of ganoderan B: A glycan of Ganoderma lucidum fruit bodies
84. Mechanisms of hypoglycemic activity of aconitan A, a glycan from Aconitum carmichaeli roots
85. Isolation and hypogycemic activity of ganoderans A and B, glycans of Ganoderma lucidum fruit bodies
86. Isolation and hypoglycemic activity of dioscorans A,B,C.,D,E,and F: Glycans of Dioscorea japonica rhizophors
87. Isolation and hypoglycemic activity of moran A, a glycoprotein of Morus alba root barks
88. Isolation and hypoglycemic activity of oryzarans A,B,C and D: Glycans of Oryza sativa roots
89. Isolation and hypoglycemic activity of panaxans F,G and H, glycans of Panax ginseng roots
90. Isolation and hypoglycemic activity of arborans A and B, glycans of Aloe arborescens var. natalensis leaves
91. Isolation and hypoglycemic activity of oryzabrans A,B,C and D, glycans of Oryza sativa bran
92. Increase in cAMP levels in β-cell line potentiates insulin secretion without altering cytosolic free-calcium concentration
93. Pharmacological modification of digestion and absorption
94. No glycémic benefit from guar administration in NIDDM
95. The hypoglucemic effect of Opuntia streptacantha studied in different animal experimental models
96. Treatment of non-insulin-dependent diabetes mellitus and its complications. A state of the art review
97. Drug screening and evaluative procedures
98. Downregulation of protein kinase C and insulin-stimulated 2-deoxyglucose uptake in rat adipocytes by phorbol esters, glucose and insulin
99. A review of natural products and plants as potential antidiabetic drugs
100. Hypoglycaemic drugs of Indian indigenous origin
101. Insulin-stimulated glucose transport and insulin internalization share a common postbinding step in adipocytes
102. Allotransplantation of islet endocrine aggregates
103. Emeriamine, an antidiabetic β-aminobetaine derived from a novel fungal metabolite
104. Effects of leguminous seeds in a mixed diet in non-insulin-dependent diabetic patients
105. Oral hypoglycaemic activity of some medicinal plants of Sri Lanka
106. In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus
107. Measurement of rat insulin. Enzyme-linked immunosorbent assay with increased sensitivity, high accuracy and greater practicability than established radioimmunoassay
108. A preliminary study of the hypoglycaemic properties of indigenous plants
109. Hypoglycemic activity of polypeptide-p from a plant source
110. Effects of the extract of Ganoderma lucidum on blood glucose level in rats
111. Carcinogenic and cocarcinogenic toxins from plants
112. Principles of toxicology
113. Effects of certain nonsteroid anti-inflammatory drugs, tolbutamide, and tetrahy-droalstonine on blood glucose and carrageenin-induced pedal edema in rats
114. Insulin-like growth factor-1 therapy in diabetes: physiologic basis, clinical benefits, and risks
115. Evaluation of ELISA for detecting in vivo chemical immunomodulation
116. Isolation and hypoglycemic activity of lithospermans A, B and C, glycans of Lithospermun erythrorhizon roots
117. Isolation and hypoglycemic activity of ephedrans A, B, C., D and E, glycans of Ephedra distachya herbs
118. Isolation and hypoglycemic activity of panaxans Q, R, S, T, and U, glycans of Panax ginseng roots
119. Isolation and hypoglycemic activity of aconitans A, B, C and D, glycans of Aconitum carmichaeli roots
120. Isolation and hypoglycemic activity of atractans A, B and C., glycans of Atractylodes japonica rhizomes
121. Insulin and oral hypoglycemic drugs; glucagon
122. Mechanisms of nicotinamide and thymidine protection from alloxan and streptozocin toxicity
123. Legume diets for diabetics?
124. Effect of an α-glycosidase inhibitor on experimentally-induced obesity in mice
125. Alloxan: History and mechanism of action
126. How cells absorb glucose
127. Herbs and botanical preparations
128. Herbs and botanical preparations
129. Traditional herbal medicines
130. Ethanol and its novel metabolites inhibit insulin action on adipocytes
131. Pharmacology of a hypoglycemic principle isolated from the fruits of Momordica charantia
132. Is the Tecoma stans infusion an antidiabetic remedy? J
133. Intervention at diagnosis of Type I Diabetes using either antioxidants or photopheresis
134. Examination of naturally occurring acetylenes for their ability to induce cytogenetic damage
135. Insulin immunoassay by back-titration using alcohol precipitation of insulin-antibody complexes
136. Structure-activity studies of photoactivated antiviral and cytotoxic tricyclic thiophenes
137. Introduction: the dynamics of drug absorption, distribution, and elimination
138. Evidence for two independent pathways of insulin-receptor internalization in hepatocytes and hepatoma cells
139. Effect of tolazamide on basal ketogenesis, glycogenesis, and gluconeogenesis in liver obtained from normal and diabetic rats
140. Dietary cyanide and tropical malnutrition diabetes
141. Hepatic glycogenolysis produced by intraperitoneal administration of total extract of Tecoma stans in rats
142. Histaminic resopnse induced by the intravenous administration of Tecoma stans crude extract in the dog
143. An in vitro study on the effect of Momordica charantia on glucose uptake and glucose metabolism in rats
144. Chromium in human nutrition: a review
145. 2+ mobilization and protein kinase C
146. Brine shrimp: A convenient general bioassay for active plant constituents
147. The hypoglycemic and insulinase-inhibitory action of some plant growth regulators
148. Hypoglycaemic effect of trigonelline
149. + channel in human pancreatic islet cells
150. Islet-cell antibodies: Markers of a more severe insulindependent diabetes mellitus?
151. Herbs and botanical preparations
152. A preliminary study of the effects of some West Indian medicinal plants on blood sugar levels in the dog
153. The balsam pear — an edible, medicinal, and toxic plant
154. A study on the crude antidiabetic drugs used in Arabian folk medicine
155. Family of glucose-transporter genes. Implications for glucose homeostasis and diabetes
156. Molecular biology of insulin resistance
157. Indigenous plants used in the control of diabetes
158. Insulin-like molecules in Momordica charantia seeds
159. Hypoglycemic constituents of Panax ginseng
160. Role of chance observation in chemotherapy: Vinca rosea
161. The West Indian weedwoman of the United States Virgin Islands
162. Catecholamines and tumor promoting phorbolesters inhibit insulin receptor kinase and induce insulin resistance in isolated human adipocytes
163. A neutral constituent of Momordica foetida
164. Oral hypoglycaemic plants in West Africa
165. Plants with oral hypoglycaemic action
166. The effect of vitamin E on glycosylated hemoglobin levels in diabetic rats: A preliminary report
167. Improved insulin response by chronic magnesium administration in aged NIDDM subjects
168. Insulin plus a sulfonylurea agent for treating Type II diabetes
169. On the way to the automated (blood) glucose regulation in diabetes: The dark past, the grey present and the rosy future
170. Molecular mechanisms of insulin resistance
171. Purified islet cells in diabetes research?
172. The biosociology of pancreatic β cells
173. Transplantation of purified islet cells in diabetic rats
174. Effect of Momordica charantia (cundeamor) in diabetes mellitus. I. A test for hypoglycemic activity in an alcoholic extract
175. Mechanisms for hyperglycemia in type II diabetes mellitus: therapeutic implications for sulfonylurea treatment — an update
176. Insulin production and glucose metabolism in isolated pancreatic islets of rats with NIDDM
177. Medicinal plants with hypoglycemic activity.J
178. Karela and diabetes
179. Insulin resistance: A look at the role of insulin receptor kinase
180. An evaluation of the potential side effects of α-glucosidase inhibitors used for the management of diabetes mellitus
181. Castanospermine blocks the hyperglycemic response to carbohydrates in vivo: a result of intestinal disaccharidase inhibition
182. Physiopathologic and clinical therapeutic effects of an alkaloid from Rauwolfia serpentina and of its total extracts. 1. Glycemic changes caused in normo- and hypoglycemic subjects by reserpine, total extracts plus glucose, insulin and adrenaline
183. A method for the mass isolation of islets from the adult pig pancreas
184. Automated method for isolation of human pancreatic islets
185. Extrapancreatic action of the sulfonylurea gliquidone. Post-receptor effect on insulin-stimulated glycogen synthesis in rat hepatocytes in primary culture
186. Preliminary chemical and pharmacological studies on “cundeamor,” Momordica charantia, I
187. Preliminary chemical and pharmacological studies on “cundeamor,” Momordica charantia, II
188. Eicosanoids as pluripotential modulators of pancreatic islet function
189. Different types of postinsulin receptor defects contribute to insulin resistance in hearts of obese Zucker rats
190. Speculations on etiology of diabetes mellitus
191. A new approach to the oral administration of insulin and other peptide drugs
192. Potentiation of insulin action by a sulfonlyurea in primary cultures of hepatocytes from normal and diabetic rats
193. Second messengers of insulin action
194. Insulin-stimulated hydrolysis of a novel glycolipid generates modulators of cAMP phosphodiesterase
195. Prevalence of diabetes mellitus in Alaskan Eskimos, Indians and Aleuts
196. Hypoglycaemic effect of Trigonella foenum graecum and Lupinus termis (Leguminosae) seeds and their major alkaloids in alloxan-diabetic and normal rats
197. Traditional medicine in Fiji some herbal folk cures used by Fiji Indians
198. Reevaluation of a biguanide, metformin mechanism of action and tolerability
199. Relative sensitivities of forward and reverse mutation assays in Salmonella typhimurium
200. Quantitative forward mutation assay in Salmonella typhimurium using 8-azaguanine resistance as a genetic marker
201. Non-hormonal hypoglycaemic compounds. Hypoglycaemia caused by indole and quinoline derivatives
202. Tropical rain forests: Potential source of new drugs?
203. Minimal effects of phorbol esters on glucose transport and insulin sensitivity of rat skeletal muscle
204. Introduction: Chemistry and coevolution
205. The aetiology of insulin dependent diabetes mellitus
206. Plant folklore. A tool for predicting sources of antitumor activity?
207. Mechanisms of hypoglycemic activity of panaxans A and B, glycans of Panax ginseng roots. Effects on the key enzymes of glucose metabolism in the liver of mice
208. Mechanisms of hypoglycemic activity of panaxans A and B, glycans of Panax ginseng roots. Effects on plasma level, secretion, sensitivity and binding of insulin in mice
209. Alkaloids of Vinca rosea (Catharanthus roseus). XXVIII. A preliminary report on hypoglycemic activity
210. Alkaloids of Vinca rosea Linn. (Catharanthus roseus G. Don.) V
211. A rapid and sensitive bioassay involving cultured rat glioma cells to screen for substances capable of elevating intracellular cyclic AMP concentration
212. Traditional plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice
213. Glycaemic effects of traditional European plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice
214. Hypoglycemic effect of the venom from the snake Piscivorus piscivorus
215. Isolation and hypoglycemic activity of anemarans A, B, C and D, glycans of Anemarrhena asphodeloides rhizomes
216. Isolation and hypoglycemic activity of saccharins A, B, C., D, E and F, glycans of Saccharum officinarum stalks
217. Isolation and hypoglycemic activity of coixans A, B, and C., glycans of Coix lachrymajobi var. ma-yuen seeds
218. Isovaleric and α-methylbutyric acidemias induced by hypoglycin A mechanism of Jamaican vomiting sickness
219. Phytochemistry and angiosperm phylogeny. A summary statement
220. Metabolic responses of rats to chronic theophylline ingestion
221. Anti-complementary and hypoglycemic activities of the glycans from the seeds of Malva verticillata
222. Hypoglycemic activity of twenty plant mucilages and three modified products
223. Inactivation and mutagenesis by phototoxins using E. coli strains differing in sensitivity to near and far UV light
224. Plight of plant-drug research in the United States today
225. Herbal medicine in America
226. Diabetes Mellitus
227. Tumor-promoting phorbol esters increase basal and inhibit insulin-stimulated lipogenesis in rat adipocytes without decreasing insulin binding
228. 2+ and hormones in isolated rat hepatocytes
229. Immunosuppressive drugs to prevent diabetes
230. Metabolic effects of hypogycin and methylenecyclopropaneacetic acid
231. Effects of a hypoglycemic component of Ginseng radix on insulin biosynthesis in normal and diabetic animals
232. Taxol. Discovery to clinic
233. Drugs that inhibit adrenergic nerves and block adrenergic receptors
234. Characteristics of insulin and glucagon release from the perfused pancreas, intact isolated islets and dispersed islet cells
235. Extra-pancreatic effects of Momordica charantia in rats
236. Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes
237. Magnesium and diabetes a review
238. Why are secondary metabolites (natural products) biosynthesized?
239. Ethnobotanical treatments of diabetes in Baja California Norte
240. A method for the immunoassay of insulin
241. Insulin immunoassay by back-titration. Some characterisitics of the technic and the insulin precipitant action of alcohol
242. Radioimmunoassay a probe for the fine structure of biologic systems
243. Assay of glucose transport in human fat cells obtained by needle biopsy
244. Inhibition of intestinal α-glucosidase activity and postprandial hypoglycemia by moranoline and its N-alkyl derivatives
245. Evaluation of inhibitory guanine nucleotide regulatory protein G function in hepatocyte and liver membranes from obese Zucker (fa/fa) rats and their lean (Fa/?) littermates
246. Modulation of insulin secretion from β-cells by phosphoinositide-derived second-messenger molecules
247. 3H] inositol efflux, inositol phosphate accumulation and insulin release from isolated rat islets